The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

TORONTO, ONTARIO / ACCESS Newswire / January 15, 2026 / Aclara Resources Inc. ("Aclara" or the "Company") is pleased to announce that its U.S.-based subsidiary, Aclara Technologies Inc.

TORONTO, ONTARIO / ACCESS Newswire / January 15, 2026 / Aclara Resources Inc. ("Aclara" or the "Company") (TSX:ARA) is pleased to announce that its U.S.-based subsidiary, Aclara Technologies Inc., has ...

Genialis Expressions empowers drug development teams to make confident decisions by unifying workflows and standardizing omics data for enterprise-grade clarity and comparability across studiesBOSTON ...

In sweeping changes to the childhood vaccine schedule, the Centers for Disease Control and Prevention no longer recommends ...

When the four-member crew of Axiom-2 launched into space in May 2023 their 10-day mission was chock full of experiments aimed at understanding human ...

A new battery tech just changed the game. It's cleaner, safer, and stores 4x more energy—without the explosion risk.

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

Matthew Schwab, CEO of Stallion Uranium, added, “This survey represents a key technical milestone at Moonlite. The ...

Jan. 8, 2026 at 8:00 a.m. ET Chairman, President, and Chief Executive Officer — Neil Ashe Senior Vice President and Chief ...

As hybrid work and global collaboration become the norm, creative teams face mounting friction. Designers need real-time ...